Skip to content

The Pros and Cons of Using SafeTraces PathogenSentinel Technology>>>

By INDEX Editorial Team | Based on peer-reviewed research –

A closer look at how this qPCR-based airborne pathogen detection system works, what it may help facility teams understand, and what its results cannot tell you on their own.

Indoor air decisions often have to be made with incomplete information. Facility managers may know a room’s ventilation design, filter type, or measured airflow, but still have questions about whether a particular airborne pathogen is present at a particular time. SafeTraces PathogenSentinel is designed to address part of that information gap: it combines air sampling with on-site quantitative polymerase chain reaction, or qPCR, testing and software for viewing results and trends. [1]

That is a potentially useful capability—but it is not the same as measuring every infectious risk, proving a room is safe, or replacing ventilation, filtration, and infection-prevention practices. For facility teams assessing the technology, the central question is not simply whether a sensor can detect a target. It is whether the complete sampling, testing, interpretation, and response process fits the building’s needs and has been validated for the intended use.

This article reviews the potential advantages and limitations of PathogenSentinel using practical evaluation criteria. Product specifications below are attributed to SafeTraces where applicable; they should not be treated as independent confirmation of system performance.

What is SafeTraces PathogenSentinel?

PathogenSentinel is an airborne pathogen detection system from SafeTraces. According to the company, it combines an air-sampling instrument, replaceable cartridges for customer-specified pathogen targets, internal qPCR analysis, and a web-based application for displaying results, alerts, and trends. SafeTraces lists a sampling rate of 100 liters per minute and says the system can be configured to detect up to four targets in a cartridge. [1] [2]

The company also states a detection sensitivity “down to 1 copy/air sample” and a seven-log dynamic range. Those are manufacturer-reported specifications, not a guarantee that every target will be detected at that level in every building or sampling condition. A facility considering the technology should request the validation data and test protocol relevant to its target organisms, environmental conditions, and use case.

It is important to distinguish PathogenSentinel from SafeTraces’ separate veriDART technology. SafeTraces describes veriDART as a building measurement-and-verification approach using synthetic, DNA-tagged aerosol tracers to assess how air moves through a space and how effectively engineering controls perform. PathogenSentinel is described as testing air samples for selected pathogen genetic targets. These approaches address related indoor-air questions, but they do not measure the same thing. [3] [4]

Evaluation criteria: eight questions to ask first

Before weighing the benefits and drawbacks, facility teams can use these criteria to assess whether a pathogen detection system is a practical fit:

  1. Target relevance: Does the system test for the specific pathogen or genetic target relevant to the facility’s concern?
  2. Sampling design: Are the sampling locations, duration, timing, and frequency appropriate for the room and decision being considered?
  3. Performance evidence: Are sensitivity, specificity, detection limits, and repeatability supported by validation under realistic conditions?
  4. Result meaning: Does a positive or negative result have a clearly defined interpretation—and does the interpretation avoid overstating infection risk?
  5. Viability distinction: Can the test tell whether detected genetic material came from viable, infectious organisms, or only establish that target nucleic acid was detected?
  6. Actionability: Are response steps defined in advance, and do they complement existing ventilation, filtration, and infection-control plans?
  7. Operating requirements: What are the equipment, cartridge, service, staffing, data, and integration requirements?
  8. Independent verification: Can the organization review methods and performance evidence beyond product claims before making a procurement decision?

These criteria apply to airborne pathogen monitoring broadly. They are not a claim that INDEX has tested or independently verified PathogenSentinel against them.

Potential advantages of PathogenSentinel

1. It combines sampling and qPCR analysis in one system

A conventional environmental testing workflow may require collecting an air sample, sending it to a laboratory, and waiting for results. SafeTraces presents PathogenSentinel as an integrated system that automates air sampling and qPCR analysis, with results displayed through an online application. If the system performs as described for a given target and setting, bringing steps on-site could help shorten the path from sample collection to reviewing a result. [1]

This could matter in settings where a facility team needs more timely information to investigate a concern or compare conditions across locations. However, “on-site” does not, by itself, establish the actual time from starting a sample to receiving a usable result. Ask the company for end-to-end turnaround times—including sampling duration, processing, and reporting—for the intended pathogen targets.

2. It can be configured for selected targets

The manufacturer says replaceable cartridges can be configured to detect up to four customer-specified pathogen targets. [2]

Target selection can be useful when a facility has a defined monitoring question, such as a particular organism of concern in a specialized environment. But a targeted test is not a survey for every pathogen in the air. Teams should confirm which targets are currently available, how target selection works, whether variants or strains affect detection, and how often cartridge configurations can be changed.

3. It may support comparisons and trend review

The company describes a web application that can show results, alerts, and trends. [1] Repeated measurements may help teams compare samples across time or locations—provided the sampling plan is consistent and the results are interpreted in context.

A trend is not automatically a risk score. Readings can be affected by where and when samples are taken, how air moves in the room, occupancy, ventilation operation, and other conditions. A useful monitoring program documents these factors and treats changes as prompts for informed review, rather than as proof of cause or safety.

4. It may help add biological information to building operations

Building teams already use data about ventilation and filtration to manage indoor environments. Pathogen target measurements could, in some settings, add a different type of information: whether selected genetic material was detected in a particular air sample. That may support investigation or help inform a broader monitoring program, especially when paired with building operations data and a clear response plan.

SafeTraces also describes APIs and data integration capabilities for its system. [1] Before relying on that feature, confirm which building-management systems and data formats are supported, what the integration can and cannot do, and how data access, security, retention, and ownership are handled.

5. It uses a recognized molecular testing approach

qPCR detects and amplifies specified nucleic-acid sequences. A 2023 peer-reviewed review of on-site airborne pathogen detection describes nucleic-acid testing as an important approach in pathogen sensing, while also outlining continuing challenges in air sampling, accurate quantification, and translating measurements into infection risk. [5]

In other words, qPCR is a meaningful analytical method, but the quality of the conclusion depends on the entire measurement chain: what gets captured from the air, how the sample is handled, which target is tested, and how the result is interpreted. A laboratory-standard analytical method does not automatically guarantee that a field system provides a complete assessment of exposure or health risk.

Potential limitations and trade-offs

1. Genetic material detection does not necessarily mean infectious pathogen detection

One of the most important questions is what a positive result means. A qPCR result can indicate that a target genetic sequence was present in the sample. It does not, on its own, establish that the material came from a viable, infectious pathogen. A peer-reviewed review of on-site airborne detection notes that many biosensing approaches based on genetic material or proteins do not inherently distinguish viable pathogens from inactivated organisms or fragments. [5]

This distinction matters in both directions. A positive result should not automatically be read as proof of an infectious dose or imminent illness. A negative result should not be read as proof that no pathogen was present anywhere in the room or that conditions will remain unchanged after sampling.

2. A sample is a snapshot, not a complete map of exposure

Airborne material can vary across a room and over time. A sampling location may not represent every occupied zone, and a sample taken at one moment cannot describe every later period. The 2023 review identifies sampling efficiency, spatial and temporal resolution, and the interpretation of measured concentrations as important challenges for on-site pathogen detection. [5]

That makes sampling design central to the value of the technology. Ask how SafeTraces recommends choosing sample locations and duration, how often sampling should occur, and what the system’s results can reasonably represent. For a large or complex building, consider whether one unit, multiple sampling points, or a separate engineering assessment would be needed to answer the facility’s question.

3. The target menu limits what the system can tell you

A system configured for a set of targets can only answer questions about those targets and the performance of the corresponding assays. SafeTraces’ public materials describe cartridges that can target up to four customer-specified pathogens. [2]

Before selecting targets, make sure the organisms align with the actual use case. Ask how targets are selected, whether testing is available for the specific organisms or variants of interest, and what happens when the target list needs to change. Also clarify what the system does not test for. A result should not be generalized beyond the organisms and conditions included in the assay.

4. Performance claims need context and independent scrutiny

SafeTraces’ product materials report sensitivity down to one copy per air sample and a seven-log dynamic range. [1] Those claims may be relevant to evaluation, but a team should ask how they were established and what the numbers mean in practice. Detection limits can depend on sampling time, collection efficiency, target type, sample matrix, and the full analytical workflow.

Request performance information for the intended target and use conditions, including false-positive and false-negative rates, reproducibility, limits of detection, and any independent or third-party validation. Also ask whether results are comparable across different units, sites, cartridge lots, or operating conditions. These are standard procurement questions—not evidence that a particular system has failed or passed them.

5. “Rapid” needs a defined clock

Marketing language such as “rapid” can mean different things. It may refer to the analysis stage alone, rather than the whole process from placing the instrument to obtaining a result. SafeTraces describes on-site qPCR testing and software-based results, but facility teams should verify the full workflow time for their specific target and sampling approach. [1]

Ask whether the system runs continuous or scheduled sampling, how often results are available, what maintenance or operator steps are needed, and what happens if a cartridge or test run produces an invalid result. These practical details influence whether the system can support real operational decisions.

6. Results are not a stand-alone measure of infection risk

A pathogen measurement is one piece of evidence, not a complete risk assessment. Infection risk depends on factors such as the organism, amount and duration of exposure, room conditions, human activity, and individual susceptibility. The peer-reviewed review emphasizes uncertainty in connecting airborne pathogen measurements to infection probability, including gaps in dose-response information and whether detected material is viable. [5]

For that reason, teams should be cautious about simple “safe/unsafe” thresholds unless the threshold is supported for the relevant pathogen, setting, exposure period, and decision. Establish in advance who will interpret results and what response they can trigger. Continue to use appropriate ventilation, filtration, maintenance, and infection-prevention measures rather than treating a sensor as a substitute for them.

7. Ownership costs and operational demands require a quote

SafeTraces directs prospective customers to request a quote; the public product information reviewed for this article does not provide a complete pricing schedule. [1] The total cost may depend on the instrument, cartridges, service, software, staff time, and the number and frequency of measurements.

Request a written estimate covering all recurring and one-time costs. Include staff training, routine maintenance, replacement parts, calibration or quality-control procedures, software subscriptions, and any costs associated with expanded sampling or system integration. A purchase price alone may not show the cost of running a sustained monitoring program.

8. Data and integrations need review before deployment

A web-based dashboard and API may be useful, but they introduce questions about network requirements, cybersecurity, access permissions, data retention, and integration support. Facility teams should confirm how results are stored and shared, who can view them, and what happens if the system is offline or a building-management connection is unavailable.

For workplaces, healthcare, education, or other sensitive environments, establish an internal policy for communicating results. A detection result without context can be misunderstood by occupants or stakeholders. Clear explanations of scope, uncertainty, and the steps being taken can support more constructive decision-making.

Who might consider evaluating it?

PathogenSentinel may merit evaluation by organizations with a defined need to test for selected airborne pathogen targets and the staff capacity to interpret results within a broader building-health program. Examples may include facility teams assessing specialized environments, or operators exploring additional measurement tools alongside established ventilation and filtration practices.

It may be a less direct fit for organizations seeking a general-purpose indoor air quality score, a personal exposure monitor, a comprehensive pathogen screen, or a stand-alone assurance that occupants face no infection risk. In those cases, first define the decision the measurement is intended to support, then compare appropriate monitoring methods and professional guidance.

Practical procurement checklist

Before requesting a demonstration or proposal, prepare questions such as:

  • Which pathogen targets are available now, and what does each assay detect?
  • What validation data support performance for the target and setting we have in mind?
  • What are the full sample-to-result times, including collection and reporting?
  • What does a positive result establish—and what does it not establish?
  • Can the test distinguish viable pathogens from genetic material or fragments?
  • How should samples be placed, timed, repeated, and compared?
  • What are all instrument, cartridge, software, service, and staffing costs?
  • What connectivity, data-security, and integration requirements apply?
  • What response actions are recommended for different result scenarios?
  • Can we review independent technical documentation before procurement?

The answers help determine whether the system addresses the facility’s real question or whether a different measurement or engineering assessment is more appropriate.

Bottom line

SafeTraces PathogenSentinel brings together air sampling, qPCR testing, and software reporting in a system intended to detect selected airborne pathogen targets. Its potential advantages include integrated testing, target-specific cartridges, and the possibility of reviewing results and trends. Its limitations include the boundaries of targeted sampling, uncertainty in translating genetic material detection into infectious risk, and the need to verify performance, workflow, cost, and data requirements for a particular use case.

The most balanced conclusion is that PathogenSentinel is a technology to assess against a specific facility need—not a substitute for core building practices, and not by itself proof that an indoor environment is safe or unsafe. Organizations should review the evidence, ask for use-case-specific validation, and set clear rules for interpreting and responding to results.

Product Criteria: SafeTraces PathogenSentinel

Criteria framework: Facility teams evaluating airborne pathogen detection systems should compare target coverage, sample design, test validation, result interpretation, operating costs, and data requirements.

Why these criteria matter: Air sampling and qPCR can provide useful information about selected genetic targets, but a result’s meaning depends on sampling conditions and does not automatically establish pathogen viability or infection probability. [5]

Practical option for consideration: SafeTraces PathogenSentinel is a commercial system described by its manufacturer as combining air sampling, on-site qPCR analysis, replaceable pathogen-target cartridges, and online results and trend reporting. [1] Interested facility teams can review the manufacturer’s specifications and request use-case-specific documentation. This is not an INDEX assessment of product performance. INDEX has no affiliate relationship with SafeTraces and does not receive a commission from this product.

Donate  →

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Back To Top
No results found...